亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials

医学 肾脏疾病 肾功能 内科学 随机对照试验 肌酐 阶段(地层学) 重症监护医学 生物 古生物学
作者
Muhammad Shahzeb Khan,George L. Bakris,Izza Shahid,Matthew R. Weir,Javed Butler
出处
期刊:JAMA Cardiology [American Medical Association]
卷期号:7 (5): 549-549 被引量:18
标识
DOI:10.1001/jamacardio.2021.5151
摘要

Importance

Cardiovascular trials have traditionally been underpowered to assess advanced chronic kidney disease (CKD) outcomes, and when included as a secondary end point, trials have used progression of CKD as incidence of some variation of a composite of end-stage kidney disease (ESKD) outcomes. Such outcomes are infrequent or occur late in cardiovascular outcome trials, which highlights the need for alternate markers for assessing the impact of interventions on kidney function at an earlier stage of the disease and, from the prevention perspective, more relevant stage of the disease.

Observations

Estimated glomerular filtration rate (eGFR) slope has demonstrated strong association with subsequent progression to ESKD. With adequate sample size, treatment effects in the range of 0.5 to 1.00 mL/min/1.73 m2/y had 96% probability of predicting CKD progression, defined as doubling of serum creatinine, eGFR less than 15 mL/min/1.73 m2, or ESKD. eGFR slope can be used in patients with higher baseline values and may provide CKD progression insights when few hard kidney events are observed, especially in trials with limited follow-up. However, among trials that have determined eGFR slope, significant variations exist regarding inclusion of baseline values, calculation of eGFR values, and the follow-up period, which make it difficult to compare and gauge the incremental benefit of the interventions. There are multiple challenges in computing eGFR slope in cardiovascular trials, such as accounting for initial eGFR dip, nonlinearity, and heteroscedasticity.

Conclusions and Relevance

eGFR slope may serve as a valuable marker to determine progression of CKD in cardiovascular trials. Further work is required to standardize data collection, follow-up duration, time points for kidney function assessment, and analytic methods to compute eGFR slope in cardiovascular trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Raul完成签到 ,获得积分10
12秒前
lql完成签到 ,获得积分10
24秒前
可爱的函函应助鲅鱼圈采纳,获得10
1分钟前
1分钟前
lzzz发布了新的文献求助10
1分钟前
英喆完成签到 ,获得积分10
1分钟前
我是老大应助畅快的毛衣采纳,获得10
1分钟前
1分钟前
1分钟前
鲅鱼圈发布了新的文献求助10
1分钟前
1分钟前
Leofar完成签到 ,获得积分10
1分钟前
1分钟前
鲅鱼圈完成签到,获得积分10
1分钟前
h0jian09完成签到,获得积分10
2分钟前
BaooooooMao完成签到,获得积分10
2分钟前
愉快的犀牛完成签到 ,获得积分10
2分钟前
Sunny完成签到,获得积分10
3分钟前
yujie完成签到 ,获得积分10
3分钟前
赘婿应助科研通管家采纳,获得10
3分钟前
3分钟前
西柚柠檬完成签到 ,获得积分10
3分钟前
心系天下完成签到 ,获得积分10
4分钟前
Alex-Song完成签到 ,获得积分0
4分钟前
不秃燃的小老弟完成签到 ,获得积分10
5分钟前
5分钟前
Owen应助科研通管家采纳,获得10
5分钟前
年年有余完成签到,获得积分10
6分钟前
胖小羊完成签到 ,获得积分10
6分钟前
7分钟前
领导范儿应助科研通管家采纳,获得10
7分钟前
7分钟前
juan完成签到 ,获得积分10
8分钟前
学术小垃圾完成签到,获得积分10
9分钟前
叁月二完成签到 ,获得积分10
9分钟前
9分钟前
科研通AI2S应助科研通管家采纳,获得10
9分钟前
大模型应助科研通管家采纳,获得10
9分钟前
xingsixs完成签到 ,获得积分10
10分钟前
AprilLeung完成签到 ,获得积分10
11分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990447
求助须知:如何正确求助?哪些是违规求助? 3532166
关于积分的说明 11256513
捐赠科研通 3271046
什么是DOI,文献DOI怎么找? 1805207
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234